Skip to content
Disclosery

EXANE DERIVATIVES: JNJ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on JNJ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 10,612 JNJ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 10,612 shares
    Change vs previous 13F +4,965 shares

    1.08% of the 13F portfolio, value $1,883,321.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 5,647 shares
    Change vs previous 13F -3,810 shares

    0.28% of the 13F portfolio, value $1,000,742.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 9,457 shares
    Change vs previous 13F -2,386 shares

    0.39% of the 13F portfolio, value $1,617,728.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 11,843 shares
    Change vs previous 13F +2,450 shares

    0.48% of the 13F portfolio, value $1,912,550.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,393 shares
    Change vs previous 13F -4,517 shares

    0.37% of the 13F portfolio, value $1,589,904.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 13,910 shares
    Change vs previous 13F +7,765 shares

    0.69% of the 13F portfolio, value $2,285,970.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 6,145 shares
    Change vs previous 13F +4,105 shares

    0.29% of the 13F portfolio, value $967,039.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,040 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $303,703.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).